Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Camptothecin encapsulated in cationic liposomes targets tumor blood vessels

Aug. 4, 2003

MOR-201 program discontinued in Q2 at MorphoSys

Aug. 4, 2003

Neovascular targeting therapy developed at Munich Biotech

Aug. 1, 2003

New phase II trial studies of Genasense in combination with rituximab/fludarabine for CLL

Aug. 1, 2003

Aventis and ImmunoGen combine forces to develop anticancer therapeutics

Aug. 1, 2003

Human breast cancer growth inhibited by nocturnal melatonin

July 31, 2003

Evidence of antitumor effects of DMXAA in refractory solid tumors

July 31, 2003

Additive antitumor effects described for SU-5416 and dalteparin in a glioblastoma cell line

July 31, 2003

Feasibility of PACT approach to solid tumor therapy demonstrated using CVS-10290

July 30, 2003

Potential chemopreventive agents in development at SRI

July 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...